Key result
A %CV-IB <90% in the ventricular septum mid-wall layer independently predicted cardiac death or heart failure hospitalization in non-obstructive HCM (HR 6.12; 95% CI 1.62-66.6; P=0.013).
Why the study?
Does ultrasonic tissue characterization of the ventricular septum predict cardiac death or heart failure hospitalization in patients with non-obstructive hypertrophic cardiomyopathy?
Cohort (n=78)
Does ultrasonic tissue characterization of the ventricular septum predict cardiac death or heart failure hospitalization in patients with non-obstructive hypertrophic cardiomyopathy?
Hazard Ratio: 6.12 (95% CI 1.62–66.6)
p-value: p=0.013
Ultrasonic tissue characterization of the ventricular septum mid-wall layer can independently predict long-term cardiac events in patients with non-obstructive hypertrophic cardiomyopathy.
May support risk stratification in non-obstructive HCM; hypothesis-generating and should not yet change practice.
AIMS: A necropsy study of patients with hypertrophic cardiomyopathy (HCM) who died at a young age exhibited marked disarray and fibrosis in the mid-wall layer of the left ventricular (LV) myocardium. We assessed ultrasonic tissue characteristics in the three layers of the ventricular septum (VS), and correlated the result with long-term prognosis in HCM. METHODS AND RESULTS: The magnitude of cyclic variation of integrated backscatter (CV-IB) was calculated in the three layers of the VS and the whole aspect of the LV posterior wall in 58 non-obstructive HCM patients and 20 healthy controls. All HCM patients were prospectively followed for an average period of 7.1 years for the occurrence of cardiac death or hospitalization due to heart failure. Each CV-IB of four regions was lower in HCM patients than in controls (all P < 0.01). CV-IB of the VS mid-wall layer was lower in 14 HCM patients with cardiac events than in patients without (5.4 ± 0.6 vs. 7.4 ± 0.5 dB, P = 0.033) although CV-IB of three other regions did not differ between the two groups. The optical cut-off point of %CV-IB <90%, i.e. the ratio of CV-IB in the VS mid-wall layer to the mean value in the layers on both sides, was an independent predictor of cardiac events (hazard ratio, 6.12; 95% confidence interval, 1.62-66.6; P = 0.013), with a positive predictive value of 44% and particularly with a high negative predictive value of 91%. CONCLUSION: Patients with non-obstructive HCM are not likely to undergo cardiac events in the near future, when the CV-IB value is not significantly lower in the VS mid-wall layer than in the layers on both sides.
No takes yet. Share an insight, caveat, or question.
Kawasaki et al. (2010) conducted a cohort in non-obstructive hypertrophic cardiomyopathy (n=78). %CV-IB <90% in the ventricular septum mid-wall layer vs. %CV-IB ≥90% was evaluated on cardiac death or hospitalization due to heart failure (HR 6.12, 95% CI 1.62-66.6, p=0.013). A %CV-IB <90% in the ventricular septum mid-wall layer independently predicted cardiac death or heart failure hospitalization in non-obstructive HCM (HR 6.12; 95% CI 1.62-66.6; P=0.013).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: